L Švancárová

439 citations
5 papers · 338 indexed · h-index 3
Topics
Sarcoma Diagnosis and Treatment (3 papers)Vascular Tumors and Angiosarcomas (3 papers)Cancer Treatment and Pharmacology (2 papers)

In The Last Decade

L Švancárová

5 papers receiving 328 citations

Peers

L Švancárová
Comparison fields: 5 of 34
  • Pulmonary and Respiratory Medicine 306
  • Oncology 243
  • Cardiology and Cardiovascular Medicine 102
  • Pathology and Forensic Medicine 72
  • Surgery 47
Replace C. Piovesan with:
C. Piovesan Italy
Nasim Ali United Kingdom
Jeeyun Lee South Korea
Andrés Meana Spain
B. Bui-Nguyen France
Gauri Bhuchar United States
Jianmin Song China
Susan Lowenbraun United States
Anna Klimczak Poland
Eihab Abdelfatah United States
L Švancárová relative to C. Piovesan Italy C. Piovesan's profile →
Citations per field
00.5×1.6×
C. Piovesan · 1×
Citations per year

Countries citing papers authored by L Švancárová

Since Specialization
Citations

This map shows the geographic impact of L Švancárová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Švancárová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Švancárová more than expected).

Fields of papers citing papers by L Švancárová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Švancárová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Švancárová. The network helps show where L Švancárová may publish in the future.

Co-authorship network of co-authors of L Švancárová

This figure shows the co-authorship network connecting the top 25 collaborators of L Švancárová. A scholar is included among the top collaborators of L Švancárová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Švancárová. L Švancárová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 130
2 96
3 108
4
Intensive combination chemotherapy (TTL-I protocol) of large cell and immunoblastic lymphomas--long-term observation.
2
5 2

About L Švancárová

L Švancárová is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 5 papers that have together received 338 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (3 papers), Vascular Tumors and Angiosarcomas (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (306 citations), Oncology (243 citations) and Gastroenterology (39 citations). L Švancárová has collaborated with scholars based in Denmark, United Kingdom and Netherlands. Frequent co-authors include Ole S. Nielsen, Jaap Verweij, C. Hermans, M. van Glabbeke, Ian Judson, A.T. van Oosterom, Axel Le Cesne, Jean‐Yves Blay, H.J. Keizer and H.T. Mouridsen. Their work appears in journals such as European Journal of Cancer, Oncology and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026